Back to Articles

Manufacturing of CD19/20 Bispecific CAR T-Cell Therapy (IMPT-514) for the Treatment of Multiple Sclerosis

CMSC-2024

Ethan BenDavid, Josh Bangayan, Katherine Standley, Orit Foord, Melanie Munguia, Jessica Reyes, Jenny Cui poster presentation at the Consortium of Multiple Sclerosis (CMSC) Annual Meeting May 30, 2024.

View PDF

Connect with us on LinkedIn, or get in touch via email.

Linkedin-in Envelope
Menu
Contact

8501 Fallbrook Avenue, Suite 200

West Hills, CA 91304 USA

info@immpact-bio.com

(818) 857-4828

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.